Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Akoustis Technologies Inc buy HC Wainwright

Start price
€0.001
31.03.26 / 50%
Target price
€28.75
31.03.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 31.03.27. The prediction end date can be changed by HC_Wainwright at any time.
Performance without dividends (%)
Name 1w
Akoustis Technologies Inc -
iShares Core DAX® 0.751%
iShares Nasdaq 100 -1.405%
iShares Nikkei 225® 0.417%
iShares S&P 500 -0.590%

Comments by HC_Wainwright for this prediction

In the thread Akoustis Technologies Inc diskutieren
Prediction Buy
Perf. (%) -
Target price 28.750
Change
Ends at 31.03.27

Aktis Oncology (AKTS) had its price target raised by HC Wainwright from $30.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for AKTS provided by MarketBeat